symbol,statement_type,period_end,line_item,value
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,1204200000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-363300000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,End Cash Position,614800000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,616000000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,-1200000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-458800000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-30200000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-407300000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-1109900000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,171700000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,-918300000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-363300000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-363300000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,1567500000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-609800000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cfo,-100000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-238000000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Change In Payable,-49800000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,5400000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-193600000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,-196300000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,443300000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Depreciation,443300000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,5200000.0
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,
INDRAMEDCO.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,2163200000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,1307600000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-693900000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,End Cash Position,616000000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,522600000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,93400000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-323800000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-10500000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-275400000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-1584300000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,123100000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,-1013500000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-693900000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-693900000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,2001500000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-468300000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cfo,-100000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,554600000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Change In Payable,406700000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,9200000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,138700000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,-158300000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,400800000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Depreciation,400800000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,11700000.0
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,
INDRAMEDCO.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,1661100000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,998900000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-445800000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,End Cash Position,522600000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,417400000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,105200000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,-260400000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-3700000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-228400000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-1079100000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,89400000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-722700000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-445800000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-445800000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,1444700000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-98500000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cfo,-900000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,66600000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Change In Payable,286100000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,15400000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-234900000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,-95700000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,392700000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Depreciation,392700000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,8700000.0
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,
INDRAMEDCO.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,1171800000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,648200000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-294800000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,End Cash Position,417400000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,249200000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,168200000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-33700000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-6000000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-2600000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-741100000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,-241000000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,24800000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,-471100000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-294800000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-294800000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,943000000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-195100000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cfo,-100000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-34500000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Change In Payable,-281500000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-12500000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,259500000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,-25100000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,349400000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Depreciation,349400000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,57700000.0
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,
INDRAMEDCO.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,790700000.0
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,0.0
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,0.0
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,0.0
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,0.0
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,10800000.0
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cfo,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Depreciation,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,7120000.0
INDRAMEDCO.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
